相关实验视频

Updated: Jan 13, 2026

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation

Published on: June 20, 2019

纳米粒子增强的CRISPR传递:为in vivo瘤基因编辑铺平道路

Muhammad Khizar¹, Hasibullah Aminpoor², Muhammad Zaib¹

¹Faculty of Medicine, Georgian American University, Manifest Medical Research Co, Tbilisi, Georgia.

Annals of medicine and surgery (2012)

|January 7, 2026

概括

纳米粒子输送系统正在推进CRISPR/Cas基因编辑用于癌症治疗. 这项技术在体内基因淘汰和瘤抑制方面表现有前途,提供了新的精确瘤治疗方法.

科学领域:

生物技术是生物技术.
在瘤学瘤学.
纳米医学是一种纳米医学.

背景情况:

克里斯普尔/卡斯技术提供了精确的基因编辑能力.
基于纳米粒子的系统增强了CRISPR组件的稳定性,循环和准.
2001年NTLA试验标志着使用脂质纳米粒子在人体体内体内的CRISPR输送的里程碑.

研究的目的:

审查纳米粒子增强CRISPR/Cas用于癌症治疗的当前进展和挑战.
突出这项技术在瘤学的体内基因编辑方面的潜力.
强调需要在完善交付平台和协议方面进行全球合作.

主要方法:

在各种纳米粒子类型 (脂质,聚合物,无机) 中封装CRISPR/Cas组件.
在临床前癌症模型中评估纳米粒子增强的CRISPR传递.
对临床试验数据的分析,如NTLA-2001试验,用于人体体内应用.

主要成果:

临床前研究表明,使用纳米粒子输送的CRISPR/Cas.有效的基因淘汰和瘤抑制.
在人体中成功的体内CRISPR传递是使用脂质纳米颗粒 (NTLA-2001试验) 实现的.
纳米粒子提高了CRISPR组件的稳定性,循环时间和瘤向精度.

结论:

纳米粒子增强的CRISPR/Cas传递具有精确癌症治疗的巨大潜力.
克服固体瘤输送和非目标效应等挑战对于临床翻译至关重要.
需要全球,透明的发展来为癌症患者带来基因精确疗法.

关键词:

克里斯普尔 Cas9 案例癌症治疗疗法癌症治疗在体内进行基因编辑.脂质纳米颗粒的使用方法纳米颗粒的交付方式精确瘤学精确瘤学

更多相关视频

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

相关概念视频

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...